EcoDrugPlus

Glutathione S-Transferase Pi 1

Ensembl ID : ENSDNOG00000035023
Gene Symbol: GSTP1
4 Cross references
172 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSDNOG00000004543
Gene Symbol: GSK3A
2 Cross references
259 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSDNOG00000006774
Gene Symbol: GSK3B
2 Cross references
244 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSDNOG00000016451
Gene Symbol: GNRHR
4 Cross references
242 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSDNOG00000010557
Gene Symbol: GHRHR
2 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSDNOG00000023928
Gene Symbol: GHSR
4 Cross references
211 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSDNOG00000002930
Gene Symbol: GUCY1A1
4 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSDNOG00000001462
Gene Symbol: GUCY1A2
2 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSDNOG00000013218
Gene Symbol: GUCY1B1
4 Cross references
211 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSDNOG00000011231
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSDNOG00000041834
Gene Symbol: HRH2
4 Cross references
249 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSDNOG00000042430
Gene Symbol: HDAC1
2 Cross references
281 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).